Search

everythinglearnresearchcommunity

for

Search:↓

Belimumab reduces disease activity, steroid use, and flares in lupus patients.

Ixekizumab quickly and effectively clears palmoplantar psoriasis in both adults and children.

Anifrolumab improves quality of life and reduces steroid use in SLE patients.

Dupilumab helped improve skin and prevent new lesions in a child with a rare immune disorder and severe eczema.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

Lenalidomide effectively and safely treats skin symptoms in pediatric lupus, reducing the need for prednisone.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Mogamulizumab can cause hair loss, often linked to a better treatment response.

Omalizumab may cause temporary hair loss, especially in women aged 18-60.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Azathioprine can help with relapses and disability in NMOSD but has more side effects and needs more research.

Pembrolizumab can cause unusual eyelash growth, but it may still be worth continuing if cancer treatment is effective.

Infliximab was effective in treating a scalp condition that did not respond to other treatments.

Bimekizumab effectively treats scalp cellulitis and improves quality of life.

Ruxolitinib cream effectively treats skin conditions like atopic dermatitis and vitiligo with minimal side effects.

Biologics, especially Dupilumab, are effective and safe for treating severe childhood eczema.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Thalidomide works best for skin lupus not helped by antimalarials, but has many side effects; other treatments are less effective, especially if patients also have systemic lupus.

The cream with xyloglucan, pea protein, and cactus extract works as well as the standard treatment for psoriasis and is well-tolerated.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

A skin rash after the AstraZeneca COVID-19 vaccine was treated successfully with medication.

Plerixafor may help treat pigmentation disorders by promoting skin repigmentation.

Intralesional cidofovir may be a viable alternative treatment for SCC.

These migraine prevention drugs can cause side effects like constipation, hair loss, injection site reactions, fatigue, and sometimes unexpected issues like Raynaud's phenomenon and weight gain.

The birth control pill containing ethinylestradiol and chlormadinone may help treat acne and other skin and hair conditions related to hormones.

Anifrolumab effectively improved lupus headaches in a patient unresponsive to other treatments.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

Risankizumab may help manage symptoms of dissecting cellulitis of the scalp.